Literature DB >> 2998950

Expression of the gag gene of human T-cell leukemia virus type I in Escherichia coli and its diagnostic use.

S Itamura, K Shigesada, M Imai, N Kobayashi, T Hamakado, T Harada, M Hatanaka.   

Abstract

An expression plasmid, pHY202, was constructed which directs the synthesis of a fusion protein encoded by the gag sequence of human T-cell leukemia virus type I (HTLV-I) inserted into the lacZ' gene. Escherichia coli cells harboring pHY202 produced the 43-kDal LacZ'-Gag fusion protein with a yield of approx. 0.3% of total soluble proteins. The fusion protein is specifically recognized by monoclonal antibodies against the Gag proteins p19 and p24, and could be applicable for the diagnosis of HTLV-I infection, because almost all sera from HTLV-I carriers gave a positive response in the enzyme-linked immunosorbent assay (ELISA) employing the LacZ'-Gag hybrid protein purified by immunoaffinity column chromatography.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998950     DOI: 10.1016/0378-1119(85)90203-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.

Authors:  E P Lillehoj; S S Alexander; C J Dubrule; S Wiktor; R Adams; C C Tai; A Manns; W A Blattner
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

2.  The presence of antibodies to purified p24gag protein of HTLV-I in sera of patients with systemic lupus erythematosus (SLE).

Authors:  J Higashi; S Kumagai; M Hatanaka; H Imura
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

3.  A gag-env hybrid protein of human T-cell leukemia virus type I and its application to serum diagnosis.

Authors:  T Kuga; M Yamasaki; S Sekine; M Fukui; Y Yokoo; S Itoh; M Yoshida; T Hattori; K Takatsuki
Journal:  Jpn J Cancer Res       Date:  1988-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.